Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

119.85 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
News headline image
Precision Oncology Sales Boost Guardant Health Q2 Topline, Backs FY21 Outlook, Management Updates ↗
After the market close on Thursday, Guardant Health Inc (NASDAQ: GH) reported Q2 revenues increased 39% Y/Y to $92.1 million, beating the consensus of $84.61... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Sensus Healthcare (NASDAQ:SRTS) ... 
Via Benzinga
News headline image
Guardant Health Announces New Leadership Structure Aligned with Strategic Growth Objectives and Expands Board of Directors
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Reports Second Quarter 2021 Financial Results
From Guardant Health, Inc.
Via Business Wire
Analyzing Guardant Health's Unusual Options Activity ↗
Guardant Health (NASDAQ:GH) shares experienced unusual opti... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report Second Quarter Financial Results on August 5, 2021
From Guardant Health, Inc.
Via Business Wire
News headline image
This Explosive Biotech Is Taking On a Huge New Market ↗
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space. 
Via The Motley Fool
News headline image
Guardant Health Expands Guardant360® Portfolio With New Tests for Treatment Response Monitoring and Complete Genomic Profiling
From Guardant Health, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Guardant Health Insights: Return On Capital Employed ↗
During Q1, Guardant Health's (NASDAQ:GH) reported sales totaled $78.67 million. Despite a 18.31% in earnings, the company posted a loss of $107.86 million. Guardant Health... 
Via Benzinga
News headline image
CORRECTING and REPLACING Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity
From Guardant Health
Via Business Wire
News headline image
CORRECTING and REPLACING Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers
From Guardant Health, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
News headline image
Cathie Wood, Bullish On SpaceX Partner Velo3D, Buys More SPFR Shares, Adds Vertex On Dip ↗
Cathie Wood-led Ark Investment Management on Friday bought 25,000 shares, estimated to be worth about $250,000, in Jaws Spitfire Acquisition Corp (NYSE: SPFR), the blank-check... 
Via Benzinga
News headline image
Guardant Health Announces Appointment of Chris Freeman as Chief Commercial Officer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health: Return On Capital Employed Insights ↗
In Q1, Guardant Health (NASDAQ:GH) posted sales of $78.67 million. Earnings were up 18.31%, but Guardant Health still reported an overall loss of $107.86 million. Guardant Health... 
Via Benzinga
News headline image
Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Blood Test Highly Accurate in Detecting Colorectal Cancer in Patients With Early-Stage Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Cathie Wood Buys $10.5M In Google, Loads Up Another $31.6M In Zoom ↗
Cathie Wood-led Ark Investment Management on Thursday bought 4,496 shares, estimated to be worth about $10.55 million, in Google parent Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 ↗
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... 
Via Benzinga
News headline image
Amgen's First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer ↗
The FDA has given accelerated approval to Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras... 
Via Benzinga
News headline image
Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Files Lawsuit Against Natera for Misleading Oncologists
From Guardant Health, Inc.
Via Business Wire
News headline image
Cathie Wood Loads Up Another $292K In SpaceX Partner Velo3D's SPAC ↗
Cathie Wood-led Ark Investment Management on Wednesday bought 29,301 shares, estimated to be worth about $292,131, in the SPAC Jaws Spitfire Acquisition Corp (NYSE: SPFR)... 
Via Benzinga
News headline image
Where Guardant Health Stands With Analysts ↗
Guardant Health (NASDAQ:GH) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 0 1... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
News headline image
Cathie Wood Buys Another $42M In Twitter Stock, Also Adds DraftKings, Netflix ↗
Cathie Wood-led Ark Investment Management on Monday bought 731,775 shares, estimated to be worth about $41.76 million, in Twitter Inc (NYSE: TWTR) — a day after The Bill and... 
Via Benzinga
News headline image
Cathie Wood Loads Up Yet Another $51M In Coinbase As Shares Slump Amid Bitcoin-Led Crypto Carnage ↗
Cathie Wood-led Ark Investment Management on Friday snapped up another 223,181 shares, worth about $50.7 million, in Coinbase Global Inc 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.